Medicine and Dentistry
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
24%
Adult
12%
Age
25%
Aging
14%
Airway Obstruction
8%
Analysis
18%
Antiretroviral Therapy
17%
Association
40%
Bilirubin
10%
Biological Marker
19%
Bronchodilating Agent
7%
Chronic Lung Disease
9%
Chronic Obstructive Pulmonary Disease
100%
Cognition
8%
Cohort Analysis
11%
Corticosteroid
10%
Death
8%
Diagnosis
16%
Disease Exacerbation
9%
Emphysema
11%
Follow up
14%
Forced Expiratory Volume
27%
Forced Vital Capacity
8%
Hazard Ratio
9%
Health
15%
Human Immunodeficiency Virus
87%
Human Immunodeficiency Virus Infection
16%
Infection
8%
Influenza
9%
Inpatient
26%
Insomnia
8%
Lung
55%
Man
14%
Morbidity
11%
Mortality
24%
Obstructive Lung Disease
13%
Obstructive Sleep Apnea
22%
Patient
40%
Person
12%
Placebo
13%
Prevalence
13%
Serum
8%
Silo-Filler's Disease
9%
Sleep
17%
Smoking
40%
Spirometry
20%
Symptom
13%
Therapeutic Procedure
29%
Vitamin D
16%
Woman
9%
Nursing and Health Professions
Actimetry
8%
Adverse Event
5%
Analysis
14%
Antiretroviral Therapy
10%
Asthma
6%
Biological Marker
9%
Blindness
7%
Cardiovascular Risk
5%
Chronic Lung Disease
9%
Cohort Analysis
22%
Confidence Interval
9%
Control
6%
Corticosteroid
8%
Cross-Sectional Study
6%
Diagnosis
11%
Forced Expiratory Volume
18%
Hospital
5%
Hospitalization
5%
Human Immunodeficiency Virus Infection
9%
Immune Deficiency
9%
Inflammation
9%
Insomnia
8%
Lung Disease
5%
Male
5%
Mortality
8%
Obstructive Lung Disease
44%
Odds Ratio
7%
Oxygen Desaturation
5%
Person
10%
Placebo
11%
Predictive Value
5%
Prevalence
13%
Quality of Life
6%
Screening
5%
Sleep Disordered Breathing
21%
Sleep Quality
6%
Spirometry
10%
St. George Respiratory Questionnaire
5%
Standard
6%
Symptom
12%
Time
12%
Vitamin D
9%
